Public list: BIO 2016 (619) Medical Devices (6162) Pharma Startups (6570) Neuroscience Startups (947)
Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's XeriSol and XeriJect formulation technologies allow...Show all
Company (IPO / Went public)
Phone: 844-445-5704
180 N LaSalle St
Suite 1800
Chicago, 60601
Illinois, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Stable formulations for parenteral injection of small molecule drugs | Jul 29, 2015 | Sep 08, 2020 | Patent |
Methods for producing stable therapeutic formulations in aprotic polar solvents | May 15, 2017 | Nov 26, 2019 | Patent |
Stable glucagon formulations for the treatment of hypoglycemia | Feb 21, 2014 | Jun 27, 2017 | Patent |
Methods for producing stable therapeutic formulations in aprotic polar solvents | Apr 22, 2016 | May 16, 2017 | Patent |
Compositions for rapidly treating severe hypoglycemia | Apr 01, 2015 | May 09, 2017 | Patent |